Google DeepMind– tag –
-
GitHub Repository ‘awesome-ai-for-science’ Launched, Featuring Google GNoME, Microsoft MatterGen, and Other Curated AI Tools Accelerating Scientific Discovery
GitHub (ai-boost) International Overview The 'awesome-ai-for-science' repository has been launched on GitHub, providing a curated list of AI tools and frameworks that accelerate discovery across diverse scientific fields, including physi... -
AWS Startups Advocates World Models and Multimodal AI Stack to Redefine Robotics Rules, Enabling Risk-Free Simulation-Based Learning
AWS Startups USA Overview AWS Startups proposes that leveraging world models in robotics can fundamentally redefine the field by enabling fault mode exploration, edge case iteration, and capability building in simulation without physical... -
Challenges in AI Drug Discovery Clinical Success Rates: Insilico’s Lenticelib First to Phase II, AlphaFold Accelerates Structural Biology
MDPI Switzerland Overview While AI drug discovery accelerates early-stage discovery, consistent improvement in late-stage clinical trial success rates remains a challenge. However, Insilico Medicine's lenticelib (NCT05938920) has become ... -
AI-Designed Drugs from DeepMind’s AlphaFold, Insilico, and Generate Biomedicines Advance to Mid-Late Stage Clinical Trials, Intensifying Drug Discovery Race
MedCity News USA Overview The AI drug discovery sector is intensifying as advanced AI-designed drugs are poised to deliver mid-to-late stage clinical trial results within the next two years, leveraging breakthroughs like DeepMind's Alpha... -
Google DeepMind and Meta Spearhead Curated AI Resources for Scientific Breakthroughs
GitHub USA Overview A new 'awesome-ai-for-science' GitHub repository, a meticulously curated list of AI tools and datasets, has been released to accelerate scientific discovery across physics, chemistry, biology, and materials science. S... -
Vertex AI-Designed Candidates Hit Phase 1/2 Trials, Accelerating AI-Driven Drug Discovery
Vertex AI Search (PharmaJournalist) USA Overview Multiple AI-designed drug candidates, developed using Vertex AI Search, have advanced to Phase 1 and 2 clinical trials, firmly establishing AI as a pivotal force in pharmaceutical R&D.... -
CVC Analyzes 8 Leading AI Material Development Companies: Investment Strategies and Public Market Proxies Explored
note Japan Overview From a Corporate Venture Capital (CVC) perspective, eight key AI material development companies—Cusp AI, DeepMind, Microsoft, Orbital, Matlantis, Citrine Informatics, Aionics, and Kebotix—have been analyzed. This arti... -
DeepMind’s GNoME and Microsoft’s MatterGen Drastically Accelerate AI-Driven Materials Discovery, Rapidly Screening Millions of Inorganic Crystals
AI CERTs News USA Overview Advanced AI pipelines like DeepMind's GNoME and Microsoft's MatterGen are leveraging graphene neural networks and machine learning potentials to screen millions of inorganic crystals at unprecedented speeds. Th... -
AI Drug Discovery Investment Surges to $10 Billion in 2026 with Eli Lilly Partnerships and Over 173 Clinical Programs, Highlighting Isomorphic Labs
MarketWise USA Overview Investment in AI drug discovery is booming in 2026, following Anthropic's CEO's prediction of a biotech renaissance, with AI and ML-related biopharma deals already nearing $10 billion. Key drivers include Eli Lill... -
Google Invests $75 Million in A24, Partnering with DeepMind to Revolutionize Film Production and Distribution Tools via AI
Quartz USA Overview Google has invested $75 million in independent film studio A24 and established an AI research partnership with DeepMind aimed at developing innovative new tools for film production and distribution. This landmark inve...
